Relevance of Lancet paper virtual-tumor SNV/indel benchmark to "Select a tumour DNA somatic variant-calling workflow"
- Use case
- Select a tumour DNA somatic variant-calling workflow
- Assessed by
- Lancet paper virtual-tumor SNV/indel benchmark
- Relevance
- Direct evidence
- Endpoint
- Virtual-tumour SNV and indel precision/recall/F1, true/false positive and false negative counts for Lancet and Strelka2 on a real-read synthetic tumour/normal pair
Real-read virtual-tumour spike-in directly measures somatic SNV/indel calling precision and recall, the declared benchmark endpoint, under one sequencing/normal regime.
2 reviewed evaluations
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
15 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
Citation locations1 values
| Genome-wide somatic variant calling using localized colored de Bruijn graphs amp-oncology-rna-20261007-source-pmc6123722: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints2 values
| Genome-wide somatic variant calling using localized colored de Bruijn graphs amp-oncology-rna-20261007-source-pmc6123722: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint Virtual-tumour SNV and indel precision/recall/F1, true/false positive and false negative counts for Lancet and Strelka2 on a real-read synthetic tumour/normal pair Context-only references | Genome-wide somatic variant calling using localized colored de Bruijn graphs amp-oncology-rna-20261007-source-pmc6123722: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed field links:assessed_by:amp-oncology-rna-20261007-protocol-lancet-virtual-tumor Context-only references | Genome-wide somatic variant calling using localized colored de Bruijn graphs amp-oncology-rna-20261007-source-pmc6123722: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Limitations5 values
| Genome-wide somatic variant calling using localized colored de Bruijn graphs amp-oncology-rna-20261007-source-pmc6123722: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Pinned records29 values
| Genome-wide somatic variant calling using localized colored de Bruijn graphs amp-oncology-rna-20261007-source-pmc6123722: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Rationale Real-read virtual-tumour spike-in directly measures somatic SNV/indel calling precision and recall, the declared benchmark endpoint, under one sequencing/normal regime. Context-only references | Genome-wide somatic variant calling using localized colored de Bruijn graphs amp-oncology-rna-20261007-source-pmc6123722: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Reason Add Codex-checked primary-source protocol evidence from the bounded AMP intake (rewire.it#365). Context-only references | Genome-wide somatic variant calling using localized colored de Bruijn graphs amp-oncology-rna-20261007-source-pmc6123722: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relevance direct Context-only references | Genome-wide somatic variant calling using localized colored de Bruijn graphs amp-oncology-rna-20261007-source-pmc6123722: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Revision 1 Context-only references | Genome-wide somatic variant calling using localized colored de Bruijn graphs amp-oncology-rna-20261007-source-pmc6123722: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
1 source record and release history
- Genome-wide somatic variant calling using localized colored de Bruijn graphs · Original source · Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00
Technical metadata and extraction receipts
Stable ID: use-case-mapping-amp-20261007-issue10-lancet-virtual-tumor
- field
- links:assessed_by:amp-oncology-rna-20261007-protocol-lancet-virtual-tumor
- value
- amp-oncology-rna-20261007-protocol-lancet-virtual-tumor
- relevance
- direct
- endpoint
- Virtual-tumour SNV and indel precision/recall/F1, true/false positive and false negative counts for Lancet and Strelka2 on a real-read synthetic tumour/normal pair
- rationale
- Real-read virtual-tumour spike-in directly measures somatic SNV/indel calling precision and recall, the declared benchmark endpoint, under one sequencing/normal regime.
- constraints
- Inspect every linked evaluation's source locator and preserved conflicts before citing a result.; Do not combine this mapping's evaluations with any other protocol's results.
- limitations
- Author-developed-caller evaluation, not independent reproduction.; Virtual tumor endpoint does not establish sensitivity in clinical tumors, FFPE samples, panels, ctDNA, copy-number or structural variation.; SNV printed counts agree with 31,592 truth variants. Do not repair MuTect table #calls=50,228 versus TP+FP=26,505; its row is not proposed for numerical ingestion.; Indel Lancet and Strelka2 counts agree with 4,945 truth variants. Preserve Table 1 rounding and do not recompute percentages.; Individual-condition confidence intervals unreported in Tables 1–2.
- revision
- 1
- reason
- Add Codex-checked primary-source protocol evidence from the bounded AMP intake (rewire.it#365).
- citation locators
- source id: amp-oncology-rna-20261007-source-pmc6123722; locator: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
- source locator
- amp-oncology-rna-20261007-source-pmc6123722: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
- review
- method: automated-source-review; reviewer: codex; claude-sonnet; reviewer note: Claude Sonnet AMP-integration worker, bounded transcription of Codex-checked primary values; independently reviewed by Codex (workbench/amp-supervision/primary-review.md, integration-review-corrections.md); reviewed at: 2026-10-07T13:38:59Z; note: Bounded primary-source transcription, independently Codex-checked. No new model execution, independent experimental reproduction, qualified human scientific review or clinical validation.
- reviewed evaluations
- amp-oncology-rna-20261007-issue-10-eval-lancet; amp-oncology-rna-20261007-issue-10-eval-strelka2
- pins
- record id: amp-oncology-rna-20261007-issue-10-eval-lancet; fields: status; links; attributes.origin; attributes.comparison; sha256: 9b57ade219eda2299792e8b9a1a78c201be84e12a8c4de376a8bdb85e860a605; record id: amp-oncology-rna-20261007-issue-10-eval-strelka2; fields: status; links; attributes.origin; attributes.comparison; sha256: 60ccea5af710863e53ba37b6e2d36007d74b505dedc1b948f4ffa9c538d7f5de; record id: amp-oncology-rna-20261007-issue-10-result-lancet-indel-f1-score; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: f4f22d2573e53f20ec8c4ab9dd6a9cae0868c00939be30c82303ae8187e3df7e; record id: amp-oncology-rna-20261007-issue-10-result-lancet-indel-false-negatives; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 51728922244b5a9c98bcb09c2ed042a118c4a291118461994f9224d31fd1352a; record id: amp-oncology-rna-20261007-issue-10-result-lancet-indel-false-positives; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: e3c6783402508c3ae2b725e488a383e1c40e82cfeab90ffd0f32e94565c71639; record id: amp-oncology-rna-20261007-issue-10-result-lancet-indel-precision; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 7f94492f71740373f17e1a29c99944c63c6662af363036dcbc2dd4bbf8448aa3; record id: amp-oncology-rna-20261007-issue-10-result-lancet-indel-recall; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 3117f12915411edacc60562cde3083b4680b6ec395d759ae2d2c36462bf336ba; record id: amp-oncology-rna-20261007-issue-10-result-lancet-indel-true-positives; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: b4312c9412c85d693f941dffb5b7806b6042e176c220fa9a16b79805d81f7156; record id: amp-oncology-rna-20261007-issue-10-result-lancet-snv-f1-score; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d400037e80367c4271987565a35c20658079cd430d9f64f127caae09235ed455; record id: amp-oncology-rna-20261007-issue-10-result-lancet-snv-false-negatives; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 8464a4ce4622d44b1eec92f78fca154c878ae499a29c21e99222afc65e17c903; record id: amp-oncology-rna-20261007-issue-10-result-lancet-snv-false-positives; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 22b2cb14ea1749cfbcaf482287e6afe913a2a4acb276ff84483335237d7d2c07; record id: amp-oncology-rna-20261007-issue-10-result-lancet-snv-precision; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d2241d8bbf3969530d37c150d34f79e5a4c5681d33e25a97b597797895c4fd65; record id: amp-oncology-rna-20261007-issue-10-result-lancet-snv-recall; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: fd18b7f728b763f87878544938dab4cc899738e858e8ca1af32bcdfdc95db497; record id: amp-oncology-rna-20261007-issue-10-result-lancet-snv-true-positives; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 232e4209bd892c89cce46598d557646f8e282a1638763261555247cbb891ddb9; record id: amp-oncology-rna-20261007-issue-10-result-strelka2-indel-f1-score; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 49bde76a302ede6328186fb2710aedba2b1c079d4997054daef4fc70152d5385; record id: amp-oncology-rna-20261007-issue-10-result-strelka2-indel-false-negatives; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 00f02fa1ed13ad83de6f870eeff8db5e30a4f678dd0c710ce1fb82a8ed2bc76e; record id: amp-oncology-rna-20261007-issue-10-result-strelka2-indel-false-positives; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: a2dd0262df6ba88cc068d4e74f7f2d5a1905892207d32a3d2ef2e4aeac16c799; record id: amp-oncology-rna-20261007-issue-10-result-strelka2-indel-precision; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: abc9335e039d494201d1f52b925643d42a450da8c01a75675eb5ecaae394aef2; record id: amp-oncology-rna-20261007-issue-10-result-strelka2-indel-recall; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 9c81f6e3fbcee5fdb72498a148fa5c4258321b1616a45b3019879e403fdec4fe; record id: amp-oncology-rna-20261007-issue-10-result-strelka2-indel-true-positives; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 37632ef3464cf522b79379be2e6603fe9e7290e1915da2538bc6cdd1f7c38054; record id: amp-oncology-rna-20261007-issue-10-result-strelka2-snv-f1-score; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d400037e80367c4271987565a35c20658079cd430d9f64f127caae09235ed455; record id: amp-oncology-rna-20261007-issue-10-result-strelka2-snv-false-negatives; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 2339e1a5c9b5b5b263015fa34603328baf0d0fc3477788984333537cf46f4194; record id: amp-oncology-rna-20261007-issue-10-result-strelka2-snv-false-positives; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 03b5bca5cabb3b33120a05ba6ed442e0bf00e45639872a43088d315db04f2924; record id: amp-oncology-rna-20261007-issue-10-result-strelka2-snv-precision; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 4af7a47bf93877d08b65d355c139ff67602e83c9a8e5bc55aec386d4e3859f0a; record id: amp-oncology-rna-20261007-issue-10-result-strelka2-snv-recall; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d48270ac7daa40028d469b28af238463a11b1d1b83aeb3610848c5ac2e6709ce; record id: amp-oncology-rna-20261007-issue-10-result-strelka2-snv-true-positives; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 99d250e5e9d227b0e62382980913a1f9aaedc46c87d81092f45cae316c0b9566; record id: amp-oncology-rna-20261007-protocol-lancet-virtual-tumor; fields: status; name; description; facets; source_ids; links; attributes; sha256: 16c78913a0b71bfc07c00a6ee9d0ac5144973521cd796f9546783043cd1c348c; record id: amp-oncology-rna-20261007-source-pmc6123722; fields: status; attributes.artifact_sha256; sha256: ae1690078f47ca662205382cd87a1410da28fb86f926e830c3a2f2140f0274a8; record id: use-case-tumour-dna-somatic-variant-detection; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: d36ba2079efa58ea91132fc20f54c4982a2f43a03e98bb1d3357c7eb8c263599